Qi-Nian Wu

3.3k total citations · 2 hit papers
14 papers, 1.9k citations indexed

About

Qi-Nian Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qi-Nian Wu has authored 14 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Qi-Nian Wu's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Qi-Nian Wu is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Qi-Nian Wu collaborates with scholars based in China, Sweden and United States. Qi-Nian Wu's co-authors include Rui‐Hua Xu, Zhao-Lei Zeng, Huai‐Qiang Ju, Dan Xie, Feng Wang, Zhan‐Hong Chen, Bo Li, Zexian Liu, Tiebang Kang and Jia-Huan Lu and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Molecular Cancer.

In The Last Decade

Qi-Nian Wu

14 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma

2019 606 citations Ting Li, Zhixiang Zuo et al. Molecular Cancer profile →
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer

2019 374 citations Yun Wang, Jia-Huan Lu et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Qi-Nian Wu China	13	1.6k	1.2k	262	145	142	14	1.9k
Ren Zhao China	15	721 0.5×	279 0.2×	212 0.8×	191 1.3×	89 0.6×	36	993
Jieyi Ma China	20	1.1k 0.7×	656 0.6×	171 0.7×	117 0.8×	71 0.5×	37	1.3k
Huilin Zheng China	13	719 0.5×	592 0.5×	185 0.7×	80 0.6×	142 1.0×	43	1.1k
Yuezhen Deng China	20	1.1k 0.7×	646 0.6×	421 1.6×	130 0.9×	330 2.3×	34	1.8k
Guopei Zheng China	29	1.7k 1.1×	1.1k 0.9×	549 2.1×	155 1.1×	126 0.9×	63	2.2k
Chuanhui Peng China	17	1.3k 0.8×	908 0.8×	166 0.6×	139 1.0×	79 0.6×	28	1.5k
Daimin Xiang China	17	1.2k 0.7×	764 0.7×	301 1.1×	92 0.6×	178 1.3×	28	1.6k
Yanyan Shen China	21	824 0.5×	293 0.3×	219 0.8×	138 1.0×	120 0.8×	63	1.2k
Yicong Wan China	19	1.1k 0.7×	796 0.7×	154 0.6×	332 2.3×	101 0.7×	43	1.4k

Countries citing papers authored by Qi-Nian Wu

Since Specialization

Citations

This map shows the geographic impact of Qi-Nian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi-Nian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi-Nian Wu more than expected).

Fields of papers citing papers by Qi-Nian Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi-Nian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi-Nian Wu. The network helps show where Qi-Nian Wu may publish in the future.

Co-authorship network of co-authors of Qi-Nian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Qi-Nian Wu. A scholar is included among the top collaborators of Qi-Nian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi-Nian Wu. Qi-Nian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Chen, Zhan‐Hong, Kai Yu, Jia-Huan Lu, et al.. (2020). METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway. Frontiers in Oncology. 10. 115–115. 84 indexed citations

Wang, Yun, Jia-Huan Lu, Qi-Nian Wu, et al.. (2019). LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Molecular Cancer. 18(1). 174–174. 374 indexed citations breakdown →

Li, Ting, Zhixiang Zuo, Xingyang Li, et al.. (2019). METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma. Molecular Cancer. 18(1). 112–112. 606 indexed citations breakdown →

Miao, Lei, Jingjing Qi, Qi Zhao, et al.. (2019). Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells. Theranostics. 10(2). 498–515. 100 indexed citations

Lu, Yun-Xin, Huai‐Qiang Ju, Zexian Liu, et al.. (2018). ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis. Cancer Research. 78(8). 1972–1985. 95 indexed citations

Lu, Yun-Xin, Qi-Nian Wu, Dong-liang Chen, et al.. (2018). Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation. Theranostics. 8(5). 1312–1326. 51 indexed citations

Chen, Zhan‐Hong, Miao‐Zhen Qiu, Xiang-Yuan Wu, et al.. (2018). Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients. Journal of Cancer. 9(3). 512–520. 11 indexed citations

Ju, Huai‐Qiang, Yun-Xin Lu, Dong-liang Chen, et al.. (2018). Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications. JNCI Journal of the National Cancer Institute. 111(6). 584–596. 134 indexed citations

Lu, Jia-Huan, Wei Wang, Qi Zhao, et al.. (2018). A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients. Cell Death Discovery. 4(1). 16 indexed citations

10.

Wu, Qi-Nian, Yun-Xin Lu, Yun Wang, et al.. (2017). Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance. Cancer Letters. 412. 243–255. 72 indexed citations

11.

Qiu, Miao‐Zhen, Min Chen, Jing Wang, et al.. (2017). Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer. Journal of Cancer. 8(17). 3531–3537. 22 indexed citations

12.

Lu, Yun-Xin, Dong-liang Chen, De‐Shen Wang, et al.. (2016). Melatonin enhances sensitivity to fluorouracil in oesophageal squamous cell carcinoma through inhibition of Erk and Akt pathway. Cell Death and Disease. 7(10). e2432–e2432. 51 indexed citations

13.

Lu, Yun-Xin, Huai‐Qiang Ju, Feng Wang, et al.. (2016). Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis. Cancer Letters. 380(1). 87–97. 53 indexed citations

14.

Zhang, Yan, Li‐Xu Yan, Qi-Nian Wu, et al.. (2011). miR-125b Is Methylated and Functions as a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer. Cancer Research. 71(10). 3552–3562. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact